The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
Jon David EmeryMark E JenkinsSibel SayaPatty ChondrosJasmeen OberoiShakira R OnwukaKitty NovyEmily HabgoodNapin KarnchanachariMarie PirottaEmerita Lyndal TrevenaAdrian BickerstaffeRichard De Abreu LourençoAnna CrothersDriss Ait OuakrimLouisa FlanderJames G DowtyFiona Mary WalterMalcolm ClarkSally DoncovioDariush EtemadmoghadamGeorge FishmanFinlay A MacraeIngrid M WinshipJennifer G WalkerPublished in: The British journal of general practice : the journal of the Royal College of General Practitioners (2023)
A risk assessment and decision support tool increases risk-appropriate CRC screening in those due screening. The CRISP intervention could commence in people in their fifth decade to ensure people start CRC screening at the optimal age with the most cost-effective test.